Back
CytomX Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
CTMX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
CTMX
CytomX Therapeutics
Last Price:
0.89
Seasonality Move:
13.92%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.CytomX Therapeutics Price Quote
$0.89
CytomX Therapeutics Key Stats
Sell
28
CytomX Therapeutics (CTMX)
is a Sell
Day range:
$0.86 - $0.90
52-week range:
$0.83 - $5.85
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.59
P/B ratio:
0%
Volume:
494.7K
Avg. volume:
966.4K
1-year change:
-31.01%
Market cap:
$69.7M
Revenue:
$101.2M
EPS:
$0.17
How Much Does CytomX Therapeutics Make?
-
How Much Are CytomX Therapeutics's Sales Annually?
CTMX Revenues are $101.2M -
How Much Profit Does CytomX Therapeutics's Make A Year?
CTMX net income is -$569K
Is CytomX Therapeutics Growing As A Company?
-
What Is CytomX Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.27% -
What Is CytomX Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.75%
CytomX Therapeutics Stock Price Performance
-
Did CytomX Therapeutics Stock Go Up Last Month?
CytomX Therapeutics share price went down by -19.09% last month -
Did CTMX's Share Price Rise Over The Last Year?
CTMX share price fell by -31.01% over the past 1 year
What Is CytomX Therapeutics 52-Week High & Low?
-
What Is CytomX Therapeutics’s 52-Week High Share Price?
CytomX Therapeutics has traded as high as $5.85 over the past 52 weeks -
What Is CytomX Therapeutics’s 52-Week Low Share Price?
CytomX Therapeutics has traded as low as $0.83 over the past 52 weeks
CytomX Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy CytomX Therapeutics?
-
How Much Debt Does CytomX Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does CytomX Therapeutics Have?
Cash and short term investments quarterly total is $117.6M -
What Is CytomX Therapeutics’s Book Value Per Share?
Book value per share is -0.30
Is CytomX Therapeutics Cash Flow Positive?
-
What Is CTMX Cash Flow From Operations?
Cash flow from operations (TTM) is -$88.3M -
What Is CytomX Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $5.5M -
What Is CytomX Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $97.4M
CytomX Therapeutics Return On Invested Capital
Data Unavailable
CytomX Therapeutics Earnings Date & Stock Price
-
What Is CytomX Therapeutics's Stock Price Today?
A single share of CTMX can be purchased today for 0.89 -
What Is CytomX Therapeutics’s Stock Symbol?
CytomX Therapeutics trades on the nasdaq under the ticker symbol: CTMX -
When Is CytomX Therapeutics’s Next Earnings Date?
The next quarterly earnings date for CytomX Therapeutics is scheduled on March 11, 2025 -
When Is CTMX's next ex-dividend date?
CytomX Therapeutics's next ex-dividend date is May 12, 2020 -
How To Buy CytomX Therapeutics Stock?
You can buy CytomX Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
CytomX Therapeutics Competitors
-
Who Are CytomX Therapeutics's Competitors?
Below is a list of companies who compete with CytomX Therapeutics or are related in some way:
CytomX Therapeutics Dividend Yield
-
What Is CTMX Dividend Yield?
CytomX Therapeutics’s dividend yield currently is 0% -
What Is CytomX Therapeutics’s Payout Ratio?
CytomX Therapeutics’s payout ratio is 0% -
When Did CytomX Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 25, 2024 -
What Is CytomX Therapeutics’s Dividend Per Share?
CytomX Therapeutics pays a dividend of $0.00 per share
CytomX Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 75% | 139.37% |
Revenue: | 26.71% | 95.51% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 3 |
Sell Recommendations: | 0 |
Price Target: | 5.29 |
Upside from Last Price: | 493.93% |